Khaled Girgis
Allergy & Immunology · Overland Park, KSNPI 1104813419
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $514 of the $636 with a category attached, or 80.8%. It is spread thinly across 17 manufacturers, the largest accounting for just 19.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for allergy & immunology clinicians in KS, where the typical reported total is $2,551.
Across 29 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$122
- GSK$93
- Genentech USA, Inc.$46
- Sanofi$38
- Dexcom, Inc.$37
- Shire North American Group Inc$35
- plus $265 from 11 others
What the payments were for
- Food & beverage$51481%
- Education$12219%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 2 | $122 |
| GSK | 4 | $93 |
| Genentech USA, Inc. | 3 | $46 |
| Sanofi | 2 | $38 |
| Dexcom, Inc. | 2 | $37 |
| Shire North American Group Inc | 2 | $35 |
| Amgen | 2 | $31 |
| AbbVie | 1 | $29 |
| Johnson & Johnson | 2 | $29 |
| Novartis | 1 | $29 |
| Greer Laboratories, Inc. | 1 | $28 |
| AstraZeneca | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Grifols USA, LLC | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Circassia Inc. | 1 | $11 |
How this compares
$636 in reported general payments places this provider in the 30th percentile of 33 allergy & immunology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 20 | $55,872 |
| Breo ElliptaFluticasone/Vilanterol | 52 | $29,457 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $24,698 |
| Advair HfaFluticasone Propion/Salmeterol | 48 | $21,569 |
| Arnuity ElliptaFluticasone Furoate | 43 | $18,726 |
| Incruse ElliptaUmeclidinium Bromide | 32 | $15,587 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $14,977 |
| Spiriva RespimatTiotropium Bromide | 11 | $10,327 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $8,137 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $5,231 |
| Montelukast Sodium | 380 | $4,712 |
| Famotidine | 261 | $4,298 |
| Epinephrine | 21 | $3,971 |
| BreynaBudesonide/Formoterol Fumarate | 12 | $3,686 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $3,490 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta, Incruse Ellipta, Trelegy Ellipta | $93 | $78,747146 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $26 | $32,83450 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 33 allergy & immunology providers in Kansas.
Other allergy & immunology in Overland Park
- Henry KanarekOverland Park$143K
- Celina BernabeOverland Park$95K
- William LaveryOverland Park$25K
- Sara AzzamOverland Park$19K
- Nguyen TranOverland Park$15K
- Cori PasserOverland Park$14K
- Derrick WardOverland Park$6K
- Mark NeustromOverland Park$3K
- James SternerOverland Park$3K
- H LevineOverland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.